The Influence of Neurocognitive Deficits and Symptoms on Quality of Life in Schizophrenia

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 4, 1997, Pages 235-243

  Heslegrave, Ronald J ^a   Awad, A George ^b   Voruganti, Lakshmi N P ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

Frontal impairment; Memory impairment; Neurocognitive deficits; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; QUALITY OF LIFE; SCHIZOPHRENIA;

ADULT; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0031184384     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Awad AG. 1992. Quality of life of schizophrenics on medications - implications for clinical trials of new neuroleptics. Hosp Community Psychiatry 43:262-5.
2. Awad AG, Voruganti LNP, Heslegrave RJ. 1995. The aims of antipsychotic medication: what are they and are they being achieved? CNS Drugs 4:8-16.
3. Balogh DW, Merritt RD. 1987. Visual masking and the schizophrenia spectrum: interfacing clinical and experimental methods. Schizophr Bull 13:679-98.
4. Bergner M. 1978. The Sickness Impact Profile: a brief summary of its purpose, uses and administration. Seattle: University of Washington.
5. Bergner M. 1989. Quality of life, health status, and clinical research. Med Care 27:148-56.
6. Bergner M, Bobbit RA, Carter WB. 1981. The Sickness Impact Profile: development and final revision of the health status measure. Med Care 19:787-805.
7. Bilder RM, Turkel E, Lipschutz-Broch L, Lieberman JA. 1992. Antipsychotic medication effects on neuropsychological functions. Psychopharmacol Bull 28:353-66.
8. Cohen J. 1977. Statistical power analysis for the behavioral sciences. New York: Academic Press.
9. Cohen J. 1992. Quantitative methods in psychology. Psychol Bull 112:155-9.
10. Cromwell R, Spaulding W. 1978. How schizophrenics handle information. In: Fann W, Karacan I, Pokorny A, Williams R, editors. The phenomenology and treatment of schizophrenia. New York: Spectrum Press, p 127-52.
11. Gold JM, Harvey PD. 1993. Cognitive deficits in schizophrenia. Psychiatr Clin North Am 16:295-312.
12. Green MF. 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-30.
13. Gurin G, Verhoff J, Feld S. 1960. Americans view of their mental health. New York: Russel Sage Foundation.
14. Heaton RK. 1981. The Wisconsin Card Sorting Test. Odessa (FL): Psychological Resources.
15. Kay SR, Fiszbein A, Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261-76.
16. Kay SR, Opler LA, Lindenmayer J. 1988. Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Res 23:99-110.
17. Kay SR, Opler LA, Lindenmayer J. 1989. The Positive and Negative Syndrome Scale (PANSS): rationale and standardization. Br J Psychiatry 155:59-67.
18. Lehman A, Ward N, Linn L. 1982. Chronic mental patients: the quality of life issue. Am J Psychiatry 139:1271-6.
19. Neale J. 1971. Perceptual span in schizophrenia. J Abnorm Psychol 77:196-204.
20. Nuechterlein KH, Dawson ME. 1984. Information processing and attentional functioning in the developmental course of schizophrenia. Schizophr Bull 10:160-203.
21. Orzack M, Kornetsky C. 1971. Environmental and familial predictors of attention behavior in chronic schizophrenics. J Psychiatr Res 9:21-35.
22. Overall J, Gorham D. 1962. Brief Psychiatric Rating Scale. Psychol Rep 10:779.
23. Rund BR. 1993. Backward-masking performance in chronic and non-chronic schizophrenics, affectively disturbed patients and normal control subjects. J Abnorm Psychol 102:74-81.
24. Rund BR, Landro NI. 1990. Information processing: a new model for understanding cognitive disturbances in psychiatric patients. Acta Psychiatr Scand 81:305-16.
25. Saccuzzo DP, Braff DL. 1981. Early information processing deficit in schizophrenia: new findings using schizophrenic subgroups and manic controls. Arch Gen Psychiatry 38:175-9.
26. Saccuzzo DP, Schubert DL. 1983. Backward masking as a measure of slow processing in schizophrenia spectrum: a reply to Schwartz [letter]. J Abnorm Psychol 92:503.
27. Schuck JR, Lee RG. 1989. Backward masking, information processing and schizophrenia. Schizophr Bull 15:491-500.
28. Schwartz BD. 1983. Comment on backward masking as a measure of slow processing in schizophrenia spectrum disorders by Saccuzzo and Schubert [letter]. J Abnorm Psychol 92:504.
29. Singh M, Kay SR. 1975. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Psychopharmacologia 43:103-13.
30. Spaulding W, Garbin CP, Crinean WJ. 1989a. The logic and psychometric prerequisites for cognitive therapy in schizophrenia. Br J Psychiatry 155:69-73.
31. Spaulding W, Garbin CP, Dras SR. 1989b. Cognitive abnormalities in schizophrenic patients and schizotypal college students. J Nerv Ment Dis 177:717-28.
32. Spaulding W, Hargrove S, Crinean WJ, Martin T. 1981. A micro-computer based laboratory for psychopathology research in rural settings. Behav Res Methods Instrumentation 13:616-23.
33. Stanovich KE, Purcell DG. 1981. Comment on input capability and speed of processing in mental retardation by Saccuzzo, Kerr, Marcus, and Brown. J Abnorm Psychol 90:168-71.
34. Wyatt R. 1976. Biochemistry and schizophrenia, part IV: the neuroleptics - their mechanism of action: a review of the biochemical literature. Psychopharmacol Bull 12:5-50.